Benlysta (belimumab) - GSK
Arzerra (ofatumumab) - Novartis, Genmab
Rituxan (rituximab) - Biogen, Zenyaku Holdings, Roche
atacicept (VT-001) - Vera Therap
Ocrevus (ocrelizumab) - Roche, Biogen
obexelimab (ZB012) - Zenas BioPharma
sifalimumab (MDX-1103) - AstraZeneca
Epratucyn (epratuzumab) - Gilead
tabalumab (LY2127399) - Eli Lilly
blisibimod (A-623) - Anthera Pharma
Orencia (abatacept) - BMS
Saphnelo (anifrolumab) - AstraZeneca
http://www.ncbi.nlm.nih.gov/pubmed/37492083
 
Bin Liu; Bo Zang; Lingwei Liu; Ruiwen Liang; Xinyue Zhao; Yibing Han
 
Jul 26, 2023
 
Prev Next